Outcome of systemic to pulmonary shunts in infants with cyanotic congenital heart disease and decreased pulmonary blood flow in Srinagarind Hospital (2012-2016)

Authors

  • Ratikorn Chaisiwamongkol Department of pediatrics, Khon Kaen University
  • Arnkisa Chaikitpinyo Department of pediatrics, Khon Kaen University
  • Manat Panamonta Department of pediatrics, Khon Kaen University
  • Yuttapong Wongswadiwat Department of pediatrics, Khon Kaen University
  • Sompop Prathanee Department of surgery, Khon Kaen, University

Keywords:

Critical cyanotic congenital heart disease, Cyanotic congenital heart disease, Systemic to pulmonary shunt, Outcomes, Shunt obstruction, Mortality

Abstract

Background: Neonates with critical congenital heart disease (CCHD) can present during their birth hospitalization with approximately 25% present with life-threatening conditions. Systemic to pulmonary shunt is designed to increase pulmonary blood flow in a cyanotic child with inadequate pulmonary blood flow and occurrence of obstructive shunt is a serious complication which can lead to death.

Objectives: To evaluate the outcome of systemic to pulmonary shunt operation and the factors which were associated with systemic to pulmonary shunt thrombosis in 5-year period after the guidelines for administering aspirin after shunting were used in Srinagarind Hospital (SNH).

Methods: This was a retrospective  study. The medical records were searched by using ICD 10 codes from Srinagarind Hospital database in pediatric cardiology clinic and pediatric echocardiography clinic and all of them were targeted for review.

Results: Thirty-six cases of cyanotic congenital heart diseases with decreased pulmonary blood flow were enrolled. Diagnosis were Tetralogy of Fallot (n = 18), pulmonary atresia (n = 11), tricuspid atresia (n = 4), critical pulmonary stenosis (n = 3). There was a case (2.7%) with early shunt obstruction within the first 24 hours after operation. There were 5 (13.9%) postoperative deaths from infection (n = 4) and bleeding (n = 1). Twenty-two cases were followed up until the end of the study period, seven cases had late shunt obstruction (25.9 %). The shunt obstruction group had the median size of the main pulmonary artery (3.1 mm.) smaller than the shunt use in non-obstruction group (5.0 mm.) with statistically significant (p value 0.021). The medians right pulmonary artery (2.7 mm), the left pulmonary artery (2.8 mm.) , the body weight (3.1 kg) and the shunt size (3.5 mm.) were smaller in the shunt obstruction group than those in the shunt non-obstruction group (RPA=3.5 mm., LPA=3.5 mm., BW= 3.4 kg., shunt size=4.1 mm.) with clinically significant but not statistically significant (RPA: p value 0.054; LPA: p value 0.139; BW: p value 0.145; shunt size: p value 0. 217).

Conclusion: Early systemic to pulmonary shunt obstruction in CCHD and decreased pulmonary blood flow was low. The size of  blood vessel was the important factor of a good outcome of the operation. The mortality rate was related with other medical condition.

Downloads

Download data is not yet available.

References

Altman CA, Fulton DR, Weisman LE. Identifying newborns with critical congenital heart disease. [Internet]. 2016 [cited 20 Jan 2017]. Available from: https://www.uptodate.com/contents/identifying-newborns-with-critical-congenital-heart-disease

Agarwal A, Firdouse M, Brar N, Yang A, Lambiris P, Chan AK, et al. Incidence and management of thrombotic and thromboembolic complications following the Norwood procedure: A systematic review. Clin Appl Thromb Hemost. 2016;22:722-31.

MacMillan M, Jones TK, Lupinetti FM, Johnston TA. Balloon angioplasty for blalock-taussig shunt failure in the early postoperative period. Catheter Cardiovasc Interv. 2005;66:585-9.

Moszura T, Zubrzycka M, Michalak KW, Rewers B, Dryżek P, Moll JJ, et al. Acute and late obstruction of a modified blalock–taussig shunt: A two-center experience in different catheter-based methods of treatment. Interact Cardiovasc Thorac Surg. 2010;10:727-31.

Guzzetta NA, Foster GS, Mruthinti N, Kilgore PD, Miller BE, Kanter KR. In-hospital shunt occlusion in infants undergoing a modified blalock-taussig shunt. Ann Thorac Surg. 2013;96:176-82.

Bove T, Vandekerckhove K, Panzer J, De Groote K, De Wolf D, François K. Disease-specific outcome analysis of palliation with the modified blalock-taussig shunt. World J Pediatr Congenit Heart Surg. 2015;6:67-74.

Küçük M, Özdemir R, Karaçelik M, Doksöz Ö, Karadeniz C, Yozgat Y, et al. Risk factors for thrombosis, over shunting and death in infants after modified blalock-taussig shunt. Acta Cardiol Sin. 2016;32:337-42.

Wells WJ, Yu RJ, Batra AS, Monforte H, Sintek C, Starnes VA. Obstruction in modified blalock shunts: A quantitative analysis with clinical correlation. Ann Thorac Surg. 2005;79:2072-6.

Monagle P, Chan AK, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, et al. Antithrombotic therapy in neonates and children—antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141:e737S-e801S.

Downloads

Published

2025-12-30

How to Cite

Chaisiwamongkol, R., Chaikitpinyo, A., Panamonta, M., Wongswadiwat, Y., & Prathanee, S. . (2025). Outcome of systemic to pulmonary shunts in infants with cyanotic congenital heart disease and decreased pulmonary blood flow in Srinagarind Hospital (2012-2016). Thai Journal of Pediatrics, 64(4), 90–103. retrieved from https://he04.tci-thaijo.org/index.php/TJP/article/view/3372

Issue

Section

Original Articles